The Swiss diabetes hardware company Ypsomed is selling off its insulin pen needle and blood sugar monitoring operations, as it turns its attention toward its drug autoinjectors and digital insulin pump for closed-loop artificial pancreas systems.
Viridian Enters Autoinjector Pen Device Customization and Agreement with Ypsomed
Sept 20 (Reuters) - Swiss medical technology company Ypsomed (YPSN.S) announced on Wednesday a long-term supply deal with Novo Nordisk (NOVOb.CO) for autoinjectors, the latest sign of how the Danish drugmaker's weight-loss drug business is a boon for pharmaceutical services companies.
[1/2]A coffee machine featuring Novo Nordisk logo is seen at the company headquarters in Copenhagen, Denmark, February 5, 2020. REUTERS/Jacob Gronholt-Pedersen/File Photo Acquire Licensing Rights
Civica, Inc. has selected Ypsomed AG as the manufacturer and supplier of insulin dosing injector pens for the company’s affordable insulins.
Market Place
Share Share
Share Share
